| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Aharon Gil is a Director at DCTH, with reported holdings spanning 2 companies. Recent filings cover 4 purchases and 0 sales. Those positions are worth an estimated $60.3M at current prices.
Our model assigns Aharon Gil a middling insider score of 62/100, based on 3 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +45.2%.
Aharon Gil's largest disclosed position is in DCTH as Director, worth about $57.1M. Net of sales, the recent Form 4 record there shows accumulation of 30,882 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | NRXS Neuraxis, Inc | Director | Buy | 286,138 | $3.52 | $1,007,205.76 | New | +110.1% | - | |
| Mar 19, 2024 | DCTH Delcath Systems, Inc. | Director | Buy | 26,882 | $3.72 | $100,001.04 | +2.6% | +80.6% | +217.3% | |
| Apr 18, 2022 | DCTH Delcath Systems, Inc. | Director | Buy | 2,000 | $6.35 | $12,697.40 | +0.5% | -37.1% | -9.6% | |
| Nov 16, 2020 | DCTH Delcath Systems, Inc. | Director | Buy | 2,000 | $12.00 | $24,000.00 | +1.1% | - | - |